Skip to content

Clinical study of Abhayadi vati and laghusutshekhar in the treatment of Amlapitta.

Open randomised comparative clinical study of Abhayadi vati and laghusutshekhar in the management of Urdhwa Amlapitta. - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107206
Enrollment
216
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

K.G. Mittal Ayurved College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with classical symptoms of Urdhwa Amlapitta as mentioned in Ayurvedic Samhitas i.e. Hrut-Kantha Daha, Tikta-Amla Udgar, Shirashula, Chhardi, Aruchi, Klama, and Avipaka 2.Patients of Urdhwa Amlapitta in the age group of 20 to 60 years irrespective of gender. 3.Newly diagnosed patient of GERD or patient Known case of GERD but yet not approached any system of medication.

Exclusion criteria

Exclusion criteria: 1.Patients having a history of gastrointestinal bleeding. 2.Patients known case of Cerebral Vascular Disease, HIV, AIDS, Hep-B, Hep-C, or any other Immunosuppressive disorder. 3.Current Diagnosis or H/O of malignancy and any Mental Disorder. 4.Pregnant or breastfeeding women. 4.Any addiction like Alcoholism, Chronic chain-smoking etc. will be excluded.

Design outcomes

Primary

MeasureTime frame
To compare the effect of Abhyadi Vati and Laghushootshekhar in the management of Urdhwa AmlapittaTimepoint: AT baseline, 7th day, 14th day and 21st day

Secondary

MeasureTime frame
To study the efficacy of Abhayadi Vati & Laghu Sutshekhar on Hrut-Kantha Daha, Tikta-Amla Udgar, Shirshula, Chardi, Aruchi, Klama, Avipaka. To study the literature related to Urdhwa Amlapitta Vyadhi in Ayurved as well as Morden science To observe adverse effect if any seen. Timepoint: at baseline, 7th day ,14th day & 21st day

Countries

India

Contacts

Public ContactDr Hemant Paradkar

Ayurved Mahavidyalaya Sion

hemant.paradkar@gmail.com9987519315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026